{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T17:15:26Z","timestamp":1779383726516,"version":"3.53.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bbrc.2026.153937","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T22:38:45Z","timestamp":1778711925000},"page":"153937","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["GBT1118 voxelotor analog improves skeletal muscle function, phenotype and significantly reduced serum myopathy biomarker GDF15 in sickle cell disease mice"],"prefix":"10.1016","volume":"822","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2866-4242","authenticated-orcid":false,"given":"Marja M.","family":"Hurley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9763-3001","authenticated-orcid":false,"given":"Liping","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.153937_bib1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1146\/annurev-pathmechdis-012418-012838","article-title":"Pathophysiology of sickle cell disease","volume":"14","author":"Sundd","year":"2019","journal-title":"Annu. Rev. Pathol."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153937_bib2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1249\/MSS.0000000000001757","article-title":"How sickle cell disease impairs skeletal muscle function: implications in daily life","volume":"51","author":"Merlet","year":"2019","journal-title":"Med. Sci. Sports Exerc."},{"issue":"5","key":"10.1016\/j.bbrc.2026.153937_bib3","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0002-9343(93)90336-N","article-title":"Sickle myonecrosis revisited","volume":"95","author":"Mani","year":"1993","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bbrc.2026.153937_bib4","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bcmd.2017.05.006","article-title":"Exacerbated in vivo metabolic changes suggestive of a spontaneous muscular vaso-occlusive crisis in exercising muscle of a sickle cell mouse","volume":"65","author":"Chatel","year":"2017","journal-title":"Blood Cells Mol. Dis."},{"issue":"6","key":"10.1016\/j.bbrc.2026.153937_bib5","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1056\/NEJM199902113400615","article-title":"Myonecrosis in sickle cell anemia","volume":"340","author":"Malekgoudarzi","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.bbrc.2026.153937_bib6","doi-asserted-by":"crossref","first-page":"99","DOI":"10.7326\/0003-4819-115-2-99","article-title":"Myonecrosis and myofibrosis as complications of sickle cell anemia","volume":"115","author":"Valeriano-Marcet","year":"1991","journal-title":"Ann. Intern. Med."},{"issue":"7","key":"10.1016\/j.bbrc.2026.153937_bib7","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1136\/jcp.42.7.712","article-title":"Creatine kinase activity in sickle cell disease","volume":"42","author":"Hunt","year":"1989","journal-title":"J. Clin. Pathol."},{"issue":"5","key":"10.1016\/j.bbrc.2026.153937_bib8","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.ajpath.2015.01.023","article-title":"Evidence for a profound remodeling of skeletal muscle and its microvasculature in sickle cell anemia","volume":"185","author":"Ravelojaona","year":"2015","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.bbrc.2026.153937_bib9","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1152\/japplphysiol.00333.2022","article-title":"Effects of hydroxyurea on skeletal muscle energetics and force production in a sickle cell disease murine model","volume":"134","author":"Michel","year":"2023","journal-title":"J. Appl. Physiol."},{"issue":"7","key":"10.1016\/j.bbrc.2026.153937_bib10","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJMoa2117175","article-title":"Biologic and clinical efficacy of LentiGlobin for sickle cell disease","volume":"386","author":"Kanter","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.bbrc.2026.153937_bib11","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMoa2109167","article-title":"Acute myeloid leukemia case after gene therapy for sickle cell disease","volume":"386","author":"Goyal","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"5339","key":"10.1016\/j.bbrc.2026.153937_bib12","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1126\/science.278.5339.873","article-title":"Knockout-transgenic mouse model of sickle cell disease","volume":"278","author":"Ryan","year":"1997","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bbrc.2026.153937_bib13","article-title":"Effects of GBT1118, a voxelotor analog, on bone disease in sickle cell disease mice","volume":"14","author":"Xiao","year":"2024","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.bbrc.2026.153937_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052471","article-title":"Normal muscle oxygen consumption and fatigability in sickle cell patients despite reduced microvascular oxygenation and hemorheological abnormalities","volume":"7","author":"Waltz","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.bbrc.2026.153937_bib15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/MPH.0b013e318200ef49","article-title":"Attenuated maximal muscle strength and peak power in children with sickle cell disease","volume":"33","author":"Dougherty","year":"2011","journal-title":"J. Pediatr. Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.bbrc.2026.153937_bib16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ajh.20755","article-title":"Physical fitness indices and anthropometrics profiles in schoolchildren with sickle cell trait\/disease","volume":"82","author":"Moheeb","year":"2007","journal-title":"Am. J. Hematol."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153937_bib17","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1590\/S1413-35552012005000139","article-title":"Lung function and six-minute walk test performance in individuals with sickle cell disease","volume":"18","author":"Ohara","year":"2014","journal-title":"Braz. J. Phys. Ther."},{"issue":"5","key":"10.1016\/j.bbrc.2026.153937_bib18","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1152\/japplphysiol.01099.2016","article-title":"Moderate and intense muscular exercises induce marked intramyocellular metabolic acidosis in sickle cell disease mice","volume":"122","author":"Chatel","year":"2017","journal-title":"J. Appl. Physiol."},{"issue":"3","key":"10.1016\/j.bbrc.2026.153937_bib19","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1182\/blood-2010-01-260372","article-title":"Pain-related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: modulation by cannabinoids","volume":"116","author":"Kohli","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2026.153937_bib20","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1017\/jns.2014.63","article-title":"Body composition and grip strength are improved in transgenic sickle mice fed a high-protein diet","volume":"4","author":"Capers","year":"2015","journal-title":"J. Nutr. Sci."},{"issue":"12","key":"10.1016\/j.bbrc.2026.153937_bib21","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.3324\/haematol.2015.128736","article-title":"Small-molecule nociceptin receptor agonist ameliorates mast cell activation and pain in sickle mice","volume":"100","author":"Vang","year":"2015","journal-title":"Haematologica"},{"issue":"10","key":"10.1016\/j.bbrc.2026.153937_bib22","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s12603-017-0883-6","article-title":"Changes in lean mass and serum myostatin with habitual protein intake and high-velocity resistance training","volume":"21","author":"Binns","year":"2017","journal-title":"J. Nutr. Health Aging"},{"issue":"5","key":"10.1016\/j.bbrc.2026.153937_bib23","first-page":"343","article-title":"Serum myostatin-immunoreactive protein is increased in 60-92 year old women and men with muscle wasting","volume":"6","author":"Yarasheski","year":"2002","journal-title":"J. Nutr. Health Aging"},{"key":"10.1016\/j.bbrc.2026.153937_bib24","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5391706","article-title":"Irisin: a promising target for ischemia-reperfusion injury therapy","volume":"2021","author":"Wang","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"21","key":"10.1016\/j.bbrc.2026.153937_bib25","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1182\/blood.V120.21.1012.1012","article-title":"Leptin and adiponectin blood levels in patients with steady state sickle cell disease are related to chronic hemolytic and inflammatory biomarkers","volume":"120","author":"Alexandros Makis","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2026.153937_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.799425","article-title":"Adiponectin and disease severity in sickle cell anemia patients attending a tertiary health institution in Nnewi, Southeast Nigeria","volume":"13","author":"Okocha","year":"2022","journal-title":"Front. Genet."},{"issue":"10","key":"10.1016\/j.bbrc.2026.153937_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8101576","article-title":"Growth differentiation Factor-15 (GDF-15) is a biomarker of muscle wasting and renal dysfunction in preoperative cardiovascular surgery patients","volume":"8","author":"Nakajima","year":"2019","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.bbrc.2026.153937_bib28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.bcmd.2014.07.003","article-title":"Growth differentiation factor-15 in young sickle cell disease patients: relation to hemolysis, iron overload and vascular complications","volume":"53","author":"Tantawy","year":"2014","journal-title":"Blood Cells Mol. Dis."},{"issue":"9","key":"10.1016\/j.bbrc.2026.153937_bib29","doi-asserted-by":"crossref","first-page":"546","DOI":"10.3949\/ccjm.92a.25036","article-title":"What is the role of cystatin C in estimating glomerular filtration rate and guiding medication dosing?","volume":"92","author":"Hajj","year":"2025","journal-title":"Cleve. Clin. J. Med."},{"issue":"11","key":"10.1016\/j.bbrc.2026.153937_bib30","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1002\/pbc.25604","article-title":"Physical activity level is not a determinant of autonomic nervous system activity and clinical severity in children\/adolescents with sickle cell anemia: a pilot study","volume":"62","author":"Charlot","year":"2015","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.bbrc.2026.153937_bib31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.bcmd.2017.01.004","article-title":"Impaired muscle force production and higher fatigability in a mouse model of sickle cell disease","volume":"63","author":"Chatel","year":"2017","journal-title":"Blood Cells Mol. Dis."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26007011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26007011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T16:49:23Z","timestamp":1779382163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26007011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":31,"alternative-id":["S0006291X26007011"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153937","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GBT1118 voxelotor analog improves skeletal muscle function, phenotype and significantly reduced serum myopathy biomarker GDF15 in sickle cell disease mice","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153937","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"153937"}}